UM

Browse/Search Results:  1-9 of 9 Help

Selected(0)Clear Items/Page:    Sort:
Bioassay-Guided Isolation of Anthelmintic Components from Semen pharbitidis, and the Mechanism of Action of Pharbitin Journal article
Liu, Maoxuan, Lu, Jing Guang, Yang, Ming Rong, Jiang, Zhi Hong, Wan, Xiaochun, Luyten, Walter. Bioassay-Guided Isolation of Anthelmintic Components from Semen pharbitidis, and the Mechanism of Action of Pharbitin[J]. International Journal of Molecular Sciences, 2022, 23(24).
Authors:  Liu, Maoxuan;  Lu, Jing Guang;  Yang, Ming Rong;  Jiang, Zhi Hong;  Wan, Xiaochun; et al.
Favorite | TC[WOS]:4 TC[Scopus]:4  IF:4.9/5.6 | Submit date:2023/01/30
Anthelmintic Activity  Caenorhabditis Elegans  Mechanism  Pharbitin  Semen Pharbitidis  
Recent advances in the biosynthesis, structure–activity relationships, formulations, pharmacology, and clinical trials of fisetin Journal article
Ruting ZHONG, Mohamed A. Farag, Meiwan Che, Chengwei He, Jianbo Xiao. Recent advances in the biosynthesis, structure–activity relationships, formulations, pharmacology, and clinical trials of fisetin[J]. eFood, 2022, 3(e3).
Authors:  Ruting ZHONG;  Mohamed A. Farag;  Meiwan Che;  Chengwei He;  Jianbo Xiao
Adobe PDF | Favorite | TC[WOS]:28 TC[Scopus]:30 | Submit date:2022/07/29
Bioactivities  Fisetin  Molecular Mechanism  Pharmacokinetics  Structure–activity Relationship  
Recent advances in the biosynthesis, structure-activity relationships, formulations, pharmacology, and clinical trials of fisetin Journal article
Zhong, Ruting, Mohamed, Farag, Chen, Meiwan, He, Chengwei, Xiao, Jianbo. Recent advances in the biosynthesis, structure-activity relationships, formulations, pharmacology, and clinical trials of fisetin[J]. Google scholar, 2022, 3(1-2).
Authors:  Zhong, Ruting;  Mohamed, Farag;  Chen, Meiwan;  He, Chengwei;  Xiao, Jianbo
Favorite | TC[WOS]:28 TC[Scopus]:30 | Submit date:2022/08/29
Bioactivities  Bioavailability  Clinical Trials  Fistein  Formulation  Molecular Mechanism  Pharmacokinetics,  Structure–activity Relationship  
Structure-Activity Relationship Studies of 4-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-6-imino-N-(naphthalen-2-yl)-1,3,5-triazin-2-amine (FPMINT) Analogues as Inhibitors of Human Equilibrative Nucleoside Transporters Journal article
Li, Renkai, Mak, Winston Wing Shum, Li, Jingjing, Zheng, Chengwen, Shiu, Polly Ho Ting, Seto, Sai Wang, Lee, Simon Ming Yuen, Leung, George Pak Heng. Structure-Activity Relationship Studies of 4-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-6-imino-N-(naphthalen-2-yl)-1,3,5-triazin-2-amine (FPMINT) Analogues as Inhibitors of Human Equilibrative Nucleoside Transporters[J]. Frontiers in Pharmacology, 2022, 13, 837555.
Authors:  Li, Renkai;  Mak, Winston Wing Shum;  Li, Jingjing;  Zheng, Chengwen;  Shiu, Polly Ho Ting; et al.
Favorite | TC[WOS]:3 TC[Scopus]:3  IF:4.4/5.0 | Submit date:2022/05/17
Equilibrative Nucleoside Transporter  Fpmint  Inhibitor  Mechanism Of Action  Structure-activity Relationship  
Natural and synthetic β-carboline as a privileged antifungal scaffolds Review article
2022
Authors:  Dai, Jiang Kun;  Dan, Wen Jia;  Wan, Jian Bo
Favorite | TC[WOS]:24 TC[Scopus]:26  IF:6.0/6.1 | Submit date:2022/03/04
Antifungal  Mechanism  Structure-activity Relationships  Β-carboline  
The structure-mechanism relationship and mode of actions of antimicrobial peptides: A review Journal article
Li, Shuqin, Wang, Yajie, Xue, Zihan, Jia, Yanan, Li, Ruilin, He, Chengwei, Chen, Haixia. The structure-mechanism relationship and mode of actions of antimicrobial peptides: A review[J]. Trends in Food Science and Technology, 2021, 109, 103-115.
Authors:  Li, Shuqin;  Wang, Yajie;  Xue, Zihan;  Jia, Yanan;  Li, Ruilin; et al.
Favorite | TC[WOS]:123 TC[Scopus]:136  IF:15.1/16.4 | Submit date:2021/12/07
Activity Mechanism  Antimicrobial Peptides  Intracellular Targets  Membrane  Research Methods  Structure-activity Relationship  
Biomimetic dynamic membrane (BDM): Fabrication method and roles of carriers and laccase Journal article
Zhu, Zhenzhou, Chen, Zhe, Luo, Xiao, Liang, Wenzhong, Li, Shuyi, He, Jingren, Zhang, Wenxiang, Hao, Tianwei, Yang, Zi. Biomimetic dynamic membrane (BDM): Fabrication method and roles of carriers and laccase[J]. Chemosphere, 2020, 240(124882).
Authors:  Zhu, Zhenzhou;  Chen, Zhe;  Luo, Xiao;  Liang, Wenzhong;  Li, Shuyi; et al.
Favorite | TC[WOS]:18 TC[Scopus]:19  IF:8.1/7.7 | Submit date:2021/12/06
Biomimetic Dynamic Membrane (Bdm)  Laccase Immobilization Mechanism  Carrier Adsorption  Fabrication Method  Laccase Activity  
Inhibition of resveratrol glucosides (REs) on advanced glycation endproducts (AGEs) formation: inhibitory mechanism and structure-activity relationship Journal article
Liu, Minzhuo, Tang, Fen, Liu, Qi, Xiao, Jianbo, Cao, Hui, Chen, Xiaoqing. Inhibition of resveratrol glucosides (REs) on advanced glycation endproducts (AGEs) formation: inhibitory mechanism and structure-activity relationship[J]. Natural Product Research, 2018, 34(17), 2490-2494.
Authors:  Liu, Minzhuo;  Tang, Fen;  Liu, Qi;  Xiao, Jianbo;  Cao, Hui; et al.
Favorite | TC[WOS]:16 TC[Scopus]:14  IF:1.9/2.1 | Submit date:2021/12/06
Advanced Glycation Endproducts  Antiglycation Mechanism  Resveratrol Glucosides  Structure-activity Relationship  
Evaluating the potential of cubosomal nanoparticles for oral delivery of amphotericin B in treating fungal infection Journal article
Yang Z., Chen M., Yang M., Chen J., Fang W., Xu P.. Evaluating the potential of cubosomal nanoparticles for oral delivery of amphotericin B in treating fungal infection[J]. International Journal of Nanomedicine, 2014, 9(1), 327.
Authors:  Yang Z.;  Chen M.;  Yang M.;  Chen J.;  Fang W.; et al.
Favorite | TC[WOS]:73 TC[Scopus]:82 | Submit date:2018/10/30
Absorption Mechanism  Amphotericin b  Antifungal Activity  Glyceryl Monoolein Cubosomes  Oral Delivery